Mint Tower Capital Management B.V. »

Apellis Pharmaceuticals shares owned by Mint Tower Capital Management B.V.

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Mint Tower Capital Management B.V. from 13F filings

Historical chart of Mint Tower Capital Management B.V. investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Mint Tower Capital Management B.V. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Mint Tower Capital Management B.V.

Quarter filed Position value Share count Share price at filing
2026-03-31 $885k 22k 40.23

More positions owned by Mint Tower Capital Management B.V.

Lumentum Hldgs Note 0.500% 6/1 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Echostar Corp Note 3.875%11/3 (Principal)
Lumentum Hldgs Note 0.500%12/1 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Confluent Note1/1 (Principal)
Snowflake Note10/0 (Principal)
Uber Technologies Put Option (UBER)
Stride Note 1.125% 9/0 (Principal)
SPDR KBW Regional Banking Put Option (KRE)
Strategy Note 0.625% 3/1 (Principal)
Ball Corporation Call Option (BALL)
Launch Two Acquisition Corp. Ord Shs Cl A (LPBB)
Lafayette Digital Acquisitio Ord Class A

View all positions for Mint Tower Capital Management B.V.

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals